Article Details

Ventyx reports positive outcomes from trial of VTX3232 for Parkinson's - Clinical Trials Arena

Retrieved on: 2025-06-18 16:58:03

Tags for this article:

Click the tags to see associated articles and topics

Ventyx reports positive outcomes from trial of VTX3232 for Parkinson's - Clinical Trials Arena. View article details on hiswai:

Excerpt

The gold standard of business intelligence. ... It involved ten patients and a 28-day treatment duration with a daily dose of oral 40mg therapy.

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo